More Links in documents

Altering Behavior Can Mean a Change for the Better

Kelly Callahan, M.P.H., is director of the Carter Center’s Trachoma Control Program.

When COVID-19 appeared, the first thing public health experts advised us all to do was to wash our hands frequently and thoroughly. This is excellent advice, and it’s what the Carter Center’s Trachoma Control Program has been teaching people for 20 years.

As humans, changing our behavior is …

From the CEO | Staying Positive, Building Hope

Ambassador (ret.) Mary Ann Peters is the CEO of The Carter Center.

At this time of great challenges brought by the COVID-19 pandemic, I have been deeply moved by the commitment of our Carter Center staff to our mission to help the world’s poorest people. Indeed, our aim to wage peace, fight disease, and build hope has never been more …

From the CEO | Innovation Embedded in Center’s Activities

Ambassador (ret.) Mary Ann Peters is the CEO of The Carter Center.

In 1982, President and Mrs. Carter created a new kind of post-presidential institution, not a think tank, but an organization acting to alleviate suffering and advance human rights for the world’s poorest people. Ever since, innovation has been part of the Center’s DNA.

From the beginning, the Center …

Partnership Has Had Trachoma on the Run for 20 Years

Hard work for a good cause can be its own reward. It’s even better when you have results to show for it. In 2018 The Carter Center is marking 20 years of impact against trachoma, the world’s leading cause of preventable blindness.

Notes From the Field: In Ethiopia, We Handle Trachoma Directly

I learned how great a need there was for eye services in my community during the 10 years I spent working for the Ethiopian government as an ophthalmic expert. Ethiopia has one of the highest rates of blindness in the world, and trachoma is a major cause of this disability in my country.

It is hard to ignore the groups …

The Sight Behind the Statistic

It may be tempting to hear about a neglected disease like trachoma and the 390 million people globally at risk and think of trachoma only as another sad statistic in a world where there is too much suffering and where there are not enough solutions.

Celebrating the 100 Millionth Treatment for Blinding Trachoma

In early November, The Carter Center reached a trachoma milestone: supporting the distribution of more than 100 million doses of the trachoma-fighting drug Zithromax®, donated by Pfizer Inc. These treatments were provided over the last 11 years to trachoma-endemic communities in six African countries: Ethiopia, Mali, Nigeria, Niger, Sudan, and South Sudan.

The 100 millionth dose was distributed in Ethiopia’s …